Hepion Pharmaceuticals (HEPA) Institutional Ownership $0.17 -0.02 (-9.04%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$0.17 0.00 (-2.34%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Hepion Pharmaceuticals (NASDAQ:HEPA)CurrentInstitutional OwnershipPercentage17.24%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$283.87KNumber ofInstitutional Sellers(last 12 months)0 Get HEPA Insider Trade Alerts Want to know when executives and insiders are buying or selling Hepion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data HEPA Institutional Buying and Selling by Quarter Hepion Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Anson Funds Management LP231,849$155K0.0%N/A3.331% 8/15/2024 Armistice Capital LLC516,000$526K0.0%+32.3%9.428% 2/13/2024 Armistice Capital LLC418,000$1.35M0.0%+5.1%9.631% 11/15/2023 Armistice Capital LLC397,607$1.98M0.0%N/A10.360% 5/1/2023 Virtu Financial LLC53,501$42K0.0%+152.8%0.070% 11/7/2022 Virtu Financial LLC67,802$34K0.0%+195.6%0.089% 10/13/2022PVG Asset Management Corp107,915$55K0.2%N/A0.142% 8/12/2022 Ikarian Capital LLC410,189$235K0.0%-29.5%0.538% 2/4/2022 Envestnet Asset Management Inc.72,027$82K0.0%+87.5%0.094% 2/2/2022PVG Asset Management Corp100,089$114K0.4%+92.5%0.131% Get the Latest News and Ratings for HEPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/10/2021PVG Asset Management Corp51,989$80K0.2%-72.6%0.068% 11/9/2021BlackRock Inc.1,634,012$2.50M0.0%-1.0%2.144% 11/5/2021 PNC Financial Services Group Inc.39,034$60K0.0%N/A0.051% 10/13/2021Asset Management Corp IL ADV133,500$204K0.1%+45.9%0.175% 9/17/2021 Virtu Financial LLC113,869$225K0.0%-36.4%0.149% 8/18/2021 Ikarian Capital LLC1,365,059$2.70M0.2%N/A1.791% 8/17/2021PVG Asset Management Corp189,616$375K1.2%+1,241.0%0.249% 8/17/2021 Boothbay Fund Management LLC155,069$307K0.0%N/A0.203% 8/16/2021 Morgan Stanley91,106$180K0.0%+197,956.5%0.120% 8/16/2021 State Street Corp322,716$639K0.0%N/A0.423% 8/16/2021 Goldman Sachs Group Inc.68,399$135K0.0%N/A0.090% 8/13/2021 Altium Capital Management LP446,000$883K0.2%N/A0.585% 8/13/2021 Geode Capital Management LLC651,318$1.29M0.0%+10.6%0.854% 8/11/2021BlackRock Inc.1,649,929$3.27M0.0%-3.9%2.165% 8/6/2021Asset Management Corp IL ADV91,500$181K0.1%N/A0.120% 8/4/2021 Envestnet Asset Management Inc.92,919$184K0.0%+256.9%0.122% 8/2/2021 Advisor Group Holdings Inc.17,751$35K0.0%+94.9%0.023% 8/2/2021 McAdam LLC55,978$86K0.0%+52.8%0.073% 5/19/2021 Virtu Financial LLC179,030$329K0.0%N/A0.235% 5/14/2021PVG Asset Management Corp14,140$26K0.1%N/A0.019% 5/13/2021 Renaissance Technologies LLC157,500$290K0.0%-52.1%0.207% 5/13/2021 Bank of New York Mellon Corp48,602$89K0.0%+18.7%0.064% 5/12/2021 Northern Trust Corp145,515$268K0.0%+129.5%0.191% 5/12/2021 Geode Capital Management LLC588,718$1.08M0.0%+190.6%0.772% 5/12/2021 UBS Group AG68,202$125K0.0%+10,794.9%0.089% 5/11/2021 Rockefeller Capital Management L.P.20,000$36K0.0%N/A0.026% 5/10/2021 GSA Capital Partners LLP160,775$296K0.0%+80.5%0.211% 5/7/2021BlackRock Inc.1,716,168$3.16M0.0%+43.7%2.251% 5/6/2021 Prospera Financial Services Inc31,300$58K0.0%-20.4%0.041% 5/6/2021 Meitav Dash Investments Ltd.44,000$81K0.0%N/A0.058% Collect $7k per month from Tesla’s SECRET dividend (Ad)Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…Click here to discover the new #1 way to invest in Tesla5/4/2021 Envestnet Asset Management Inc.26,037$48K0.0%N/A0.034% 4/28/2021 JGP Wealth Management LLC15,000$28K0.0%N/A0.020% 4/26/2021 McAdam LLC36,641$67K0.0%N/A0.048% 2/17/2021 Worth Venture Partners LLC233,947$512K0.4%N/A2.592% 2/16/2021 Squarepoint Ops LLC111,978$245K0.0%+621.3%1.241% 2/12/2021 Prospera Financial Services Inc39,300$86K0.0%N/A0.435% 2/11/2021 Northern Trust Corp63,402$139K0.0%N/A0.703% 2/10/2021 Renaissance Technologies LLC329,022$721K0.0%N/A3.646% 2/9/2021 Perkins Capital Management Inc.150,000$329K0.2%N/A1.662% 2/9/2021 Bank of New York Mellon Corp40,945$90K0.0%N/A0.454% 2/5/2021BlackRock Inc.1,194,434$2.62M0.0%+1,867.1%13.235% (Data available from 1/1/2016 forward) HEPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HEPA shares? During the previous two years, the following institutional investors and hedge funds held shares of Hepion Pharmaceuticals shares: Armistice Capital LLC ($526K), and Anson Funds Management LP ($155K), Virtu Financial LLC ($42K).Learn more on HEPA's institutional investors. What percentage of Hepion Pharmaceuticals stock is owned by institutional investors? 17.24% of Hepion Pharmaceuticals stock is owned by institutional investors. Learn more on HEPA's institutional investor holdings. Which institutional investors have been buying Hepion Pharmaceuticals stock? The following institutional investors have purchased Hepion Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($544K), Anson Funds Management LP ($231.85K), and Virtu Financial LLC ($32.34K). How much institutional buying is happening at Hepion Pharmaceuticals? Institutional investors have bought a total of 808,185 shares in the last 24 months. This purchase volume represents approximately $2.84M in transactions. Related Companies IMCC Major Shareholders SYRS Major Shareholders GRI Major Shareholders SONN Major Shareholders PRTG Major Shareholders UPXI Major Shareholders GTBP Major Shareholders ADIL Major Shareholders PLRZ Major Shareholders LIPO Major Shareholders This page (NASDAQ:HEPA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hepion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hepion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
